glp 1 blue cross Blue Shield of Massachusetts will stop covering popular drugs for weight loss. Here's why As GLP-1 drug use surges

Given the potential for significant health improvements with semaglutide GLP-1 use, many find the investment worthwhile, as it may help in avoiding more expensive medical treatments in the future

This article is for general educational purposes and is not individualized medical advice

According to Roy Moore, senior healthcare research and data analyst at information services agency Clarivate, Cignas national plan used to list Zepbound and Wegovy as excluded drugs and Mounjaro and Ozempic as not covered. RELATED: Does Aetna cover Zepbound

As patients included in the study may be seeking more frequent care and/or have at least 12 months of continuous enrollment, generalizability may be limited compared with those with less healthcare utilization or baseline history

What are the side effects of using Ozempic